Showing results 6 to 11 of 11
< previous
| Issue Date | Title | Author(s) |
| 27-Dec-2022 | Elevated Circulating Lactate Levels and Widespread Expression of Its Cognate Receptor, Hydroxycarboxylic Acid Receptor 1 (HCAR1), in Ovarian Cancer | Kerslake, R; Panfilov, S; Mustafa, N; Hall, M; Kyrou, I; Randeva, H; Karteris, E; Godfrey, R |
| 10-May-2022 | Impact of environmentally relevant concentrations of Bisphenol A (BPA) on the gene expression profile in an in vitro model of the normal human ovary | Zahra, A; Kerslake, R; Kyrou, I; Randeva, HS; Sisu, C; Karteris, E |
| 8-Dec-2022 | A Meta-analysis of 2D vs. 3D Ovarian Cancer Cellular Models | Kerslake, R; Belay, B; Panfilov, S; Hall, M; Kyrou, I; Randeva, HS; Hyttinen, J; Karteris, E; Sisu, C |
| 9-Jul-2021 | A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer | Kerslake, R; Hall, M; Vagnarelli, P; Jeyaneethi, J; Randeva, HS; Pados, G; Kyrou, I; Karteris, E |
| 24-Feb-2022 | Protein expression of transmembrane protease serine 4 in the gastrointestinal tract and in healthy, cancer, and SARS‑CoV‑2 infected lungs | Kerslake, R; Randeva, HS; Jonigk, D; Werlein, C; Robertus, JL; Katopodis, P; Jasker, P; Spandidos, DA; Kyrou, I; Karteris, E |
| 26-Jun-2023 | Transcriptional Landscape of 3D vs. 2D Ovarian Cancer Cell Models | Kerslake, R; Belay, B; Panfilov, S; Hall, M; Kyrou, I; Randeva, HS; Hyttinen, J; Karteris, E; Sisu, C |
